← Companies|Esco Lifesciences
Es

Esco Lifesciences

Singapore SGFounded 19782,500 employees
Private CapbiotechPrivateOncology
Platform: Lab Equipment
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ESC-2972ESC-2972Phase 21NanobodyEGFRDLL3 ADCWilms
ESC-2069ESC-2069Phase 1/21ERTFGFRCFTRmodADHDLN
ESC-346ESC-346Phase 11Gene EditingWEE1CAR-T BCMAUCAML
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)
2025-11-17
ESC-2972 BTD
Wilms
Past
2026-03-01
ESC-346 Conference
Breast Ca
Past
2029-06-10
ESC-2972 Ph2 Data
Wilms
Ph2 Data
2030-01-04
ESC-2069 Ph2 Data
LN
Ph2 Data